Inventor · disambiguated record
Jeffrey P. Ciavarri
Also filed as: CIAVARRI JEFFREY · CIAVARRI JEFFREY P
16 granted patents·5 pending applications·59 citations·filing 2005–2024
90Inventor score
Files withMILLENNIUM PHARM INC10TAKEDA PHARMACEUTICALS CO3ASTELLAS PHARMA INC2UNIV PENNSYLVANIA2BLACKBURN CHRISTOPHER1
Top patents by PatentIndex Score
21 records- 0191US7732444B22-(amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseasesMILLENNIUM PHARM INC·Filed 2005·Granted Jun 8, 2010·25 cites·19 claims
- 0287US9290500B2Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzymeMILLENNIUM PHARM INC·Filed 2013·Granted Mar 22, 2016·10 cites·41 claims
- 0385US9096518B2Substituted hydroxamic acids and uses thereofBLACKBURN CHRISTOPHER·Filed 2010·Granted Aug 4, 2015·10 cites·28 claims
- 0482US9751854B2Heteroaryls and uses thereofMILLENNIUM PHARM INC·Filed 2016·Granted Sep 5, 2017·3 cites·8 claims
- 0581US9802960B2Heteroaryls and uses thereofMILLENNIUM PHARM INC·Filed 2015·Granted Oct 31, 2017·4 cites·29 claims
- 0679US11542293B2Sting modulator compounds, and methods of making and usingTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Jan 3, 2023·1 cites·23 claims
- 0779US7485631B2Phorboxazole compounds and methods of their preparationUNIV PENNSYLVANIA·Filed 2006·Granted Feb 3, 2009·3 cites·21 claims
- 0876US2025262298A1Sting modulator compounds with sulfamate linkages, and methods of making and usingCIAVARRI JEFFREY·Filed 2024·Application pending·0 cites
- 0975US11912679B2Aryl alkynamide derivativesASTELLAS PHARMA INC·Filed 2023·Granted Feb 27, 2024·0 cites·19 claims
- 1073US10202373B2Heteroaryls and uses thereofMILLENNIUM PHARM INC·Filed 2015·Granted Feb 12, 2019·2 cites·15 claims
- 1172US9663525B2Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzymeMILLENNIUM PHARM INC·Filed 2016·Granted May 30, 2017·1 cites·12 claims
- 1270US12054512B2Sting modulator compounds, and methods of making and usingTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Aug 6, 2024·0 cites·23 claims
- 1366US2025177349A1Aryl alkynamide derivativesASTELLAS PHARMA INC·Filed 2023·Application pending·0 cites
- 1461US10202389B2Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzymeMILLENNIUM PHARM INC·Filed 2017·Granted Feb 12, 2019·0 cites·7 claims
- 1561US9796725B2Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzymeMILLENNIUM PHARM INC·Filed 2017·Granted Oct 24, 2017·0 cites·15 claims
- 1661US2021015915A1Sting modulator compounds with sulfamate linkages, and methods of making and usingTAKEDA PHARMACEUTICALS CO·Filed 2019·Application pending·0 cites
- 1760US2009163563A1Phorboxazole Compounds and Methods of Their PreparationUNIV PENNSYLVANIA·Filed 2008·Application pending·0 cites
- 1852US10538533B2Heteroaryls and uses thereofMILLENNIUM PHARM INC·Filed 2017·Granted Jan 21, 2020·0 cites·23 claims
- 1951US2009175852A1Imidazopyrazines as protein kinase inhibitorsSCHERING CORP·Filed 2009·Application pending·0 cites
- 2044US9321731B2Substituted hydroxamic acids and uses thereofMILLENNIUM PHARM INC·Filed 2015·Granted Apr 26, 2016·0 cites·12 claims
- 2142US8268822B22-(amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseasesFLEMING PAUL E·Filed 2010·Granted Sep 18, 2012·0 cites·11 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →